Sky View Investment Advisors, LLC Novo Nordisk A S Transaction History

Sky View Investment Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$122.71 - $146.91 $6,012 - $7,198	49 Added 0.35%	14,125 $2.02 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $1.44 Million - $1.91 Million	14,076 New	14,076 $1.81 Million
Q3 2023 Nov 16, 2023	BUY	$90.94 - $199.54 $184,881 - $405,664	2,033 Added 19.68%	12,364 $1.12 Million
Q2 2023 Aug 15, 2023	BUY	$155.98 - $172.65 $440,799 - $487,908	2,826 Added 37.65%	10,331 $1.67 Million
Q1 2023 May 18, 2023	BUY	$132.34 - $159.14 $17,601 - $21,165	133 Added 1.8%	7,505 $1.19 Million
Q4 2022 Feb 16, 2023	SELL	$102.55 - $135.33 $5,332 - $7,037	-52 Reduced 0.7%	7,372 $998,000
Q3 2022 Nov 16, 2022	BUY	$95.28 - $116.93 $66,981 - $82,201	703 Added 10.46%	7,424 $740,000
Q2 2022 Nov 15, 2022	BUY	$103.24 - $121.81 $284,839 - $336,073	2,759 Added 69.64%	6,721 $748,000
Q1 2022 May 17, 2022	BUY	$93.1 - $112.54 $7,634 - $9,228	82 Added 2.11%	3,962 $441,000
Q4 2020 Mar 02, 2021	BUY	$63.89 - $73.8 $247,893 - $286,344	3,880 New	3,880 $271,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky View Investment Advisors, LLC with notifications on news.